Abstract: The present invention relates to novel piperazine derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially for targeted therapy treatment of hyperproliferative disorders, including benign hyperproliferative disorders, cancer and pre-cancer conditions.
Type:
Grant
Filed:
August 17, 2017
Date of Patent:
August 10, 2021
Assignee:
VIDAC PHARAMA LTD.
Inventors:
Paul Salama, Vered Behar, Oren Menahem Becker